[1] Wild S,Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabetes Care ,2004,27:1047-1053.
[2] Coutinho M, Wang Y, Gerstein HC, et al. The relationship between glucose and incident cardiovascular events[J]. Diabetes Care, 1999,
22:233-240.
[3] Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. Lancet, 2010,375:2215-2222.
[4] Stratton IM, Adler A, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35): prospective observational study[J]. British Medical Journal,2000,321:405-412.
[5] ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. The New England Journal of Medicine,2008,358:2560-2572.
[6] ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes[J]. The New England Journal of Medicine,2008,
358:2545-2559.
[7] Duckworth W, Abraira C, Moritz T, et al.For the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes[J]. The New England Journal of Medicine,2009,360:
129-139.
[8] UK Prospective Diabetes Study Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes, UKPDS 33[J]. Lancet ,1998,352:837-853.
[9] University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: V. Evaluation of phenformin therapy[J]. Diabetes, 1975,24:65-184.
[10] University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: V. Supplementary report on non-fatal events in patients treated with tolbutamide[J]. Diabetes,1976,25:1129-1153.
[11] University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: VIII. Evaluation of insulin therapy: final report[J]. Diabetes,1982,31:1-81.
[12] Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6 year study[J]. Diabetes Research and Clinical Practice,1995,28:103-117.
[13] Abraira C, Colwell J, Nuttall F, et al. Cardiovascular events and correlates in Veterans Affairs Diabetes Feasibility trial[J]. Archives of internal Medicine,1997,157:181-188.
[14] UK Prospective Diabetes Study (UKPDS) Group. Effect of Intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34)[J]. Lancet, 1998,352:854-865. |
